Loading
Total declarations
Companies
▲ Purchases (214 ops.)
▼ Sales (231 ops.)
Latest filing published 10 Feb 2011 for Pacira BioSciences, Inc..
Filing timeline
BuySaleHBM Bioventures Cayman Ltd
First 200 filings with a declared amount
Insider track record
Disclosed buys
214
Disclosed sells
231
Signal history
No signal scores available.
Closed purchases
Market purchases
214
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
HBM Bioventures Cayman Ltd: trading record in brief
HBM Bioventures Cayman Ltd has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Micrus Endovascular Corp and Pacira BioSciences, Inc. Between 31 January 2007 and 19 March 2013, the trades on record add up to 447 filings.
Market trades split into 214 purchases (€6.6M) and 231 sales (€27.5M). Sales outweigh purchases by €20.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2013 to date brings no purchases and 3 sales.
In size, the median ticket on the buying side is €5,843.
Most recently, on 21 March 2013, the filings show an open-market sale worth €10.7M in Pacira BioSciences, Inc. The clock since the last published purchase (22 November 2011) now reads 5,453 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to HBM Bioventures Cayman Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations433 total
1,487,680 sharesCommon StockSEC:0001104659-11-006516:0
46,196 shares@ US$21.15Common StockSEC:0001104659-10-012091:0
21,200 shares@ US$20.98Common StockSEC:0001104659-10-012091:1
40,000 shares@ US$20.02Common StockSEC:0001104659-10-009828:0
30,000 shares@ US$19.94Common StockSEC:0001104659-10-009828:1
1,940 shares@ US$21.68Common StockSEC:0001104659-10-008936:0
65,000 shares@ US$20.52Common StockSEC:0001104659-10-008936:1
21,562 shares@ US$11.00Common StockSEC:0001104659-09-050157:0
3,438 shares@ US$11.10Common StockSEC:0001104659-09-050157:1
30,628 shares@ US$11.00Common StockSEC:0001104659-09-049578:0
809 shares@ US$11.01Common StockSEC:0001104659-09-049578:1
607 shares@ US$11.02Common StockSEC:0001104659-09-049578:2
4,306 shares@ US$11.03Common StockSEC:0001104659-09-049578:3
723 shares@ US$11.04Common StockSEC:0001104659-09-049578:4
1,325 shares@ US$11.05Common StockSEC:0001104659-09-049578:5
210 shares@ US$11.06Common StockSEC:0001104659-09-049578:6
100 shares@ US$11.07Common StockSEC:0001104659-09-049578:7
428 shares@ US$11.07Common StockSEC:0001104659-09-049578:8
1,000 shares@ US$11.08Common StockSEC:0001104659-09-049578:9
2,214 shares@ US$11.09Common StockSEC:0001104659-09-049578:10
100 shares@ US$11.10Common StockSEC:0001104659-09-049578:11
1,050 shares@ US$11.10Common StockSEC:0001104659-09-049578:12
1,300 shares@ US$11.11Common StockSEC:0001104659-09-049578:13
598 shares@ US$11.12Common StockSEC:0001104659-09-049578:14
1,300 shares@ US$11.13Common StockSEC:0001104659-09-049578:15
25 of 433 declarations
